Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy.

Journal of clinical microbiology - 1 Feb 2009

Jardi Rosendo, Rodriguez-Frias Francisco, Tabernero David, Homs Maria, Schaper Melanie, Esteban Rafael, Buti Maria

Abstract excerpt

A line probe assay (INNO-LiPA DR, version 3) for the detection of hepatitis B virus mutations that confer resistance to entecavir therapy was evaluated. The INNO-LiPA DR assay is a highly sensitive assay that is easily applicable for the detection and monitoring of entecavir resistance-conferring mutations and is more sensitive than sequencing for the detection of mixed sequences.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Guanine

Share to Hepatitis B virus

Share to Molecular Diagnostic Techniques

Share to Mutation, Missense

Share to Nucleic Acid Hybridization

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 19052182
DOI: 10.1128/JCM.01678-08
PMCID: PMC2643676

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy.PMID 19052182Read ↗

Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.Semantic proximity Read ↗

Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.Semantic proximity Read ↗

Comparison of line probe assay and DNA sequencing of 5' untranslated region for genotyping hepatitis C virus: description of novel line probe patterns.Semantic proximity Read ↗

Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic hepatitis B virus infection.Semantic proximity Read ↗

Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.Semantic proximity Read ↗

Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions.Semantic proximity Read ↗

Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).Semantic proximity Read ↗

Hepatitis B viral genotyping with the research INNO-LiPA HBV genotyping line probe assay.Semantic proximity Read ↗

Validation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.Semantic proximity Read ↗

Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype.Semantic proximity Read ↗

Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.Semantic proximity Read ↗

Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.